Search results
Results from the WOW.Com Content Network
The most common side effects in dogs include gastrointestinal irritation (vomiting, diarrhea, and ulceration). [33] As far as the perioperative administration is concerned, in healthy dogs given meloxicam, no perioperative adverse effects on the cardiovascular system have been reported at recommended dosages. [ 39 ]
Frunevetmab is indicated for the alleviation of pain associated with osteoarthritis in cats. [ 3 ] [ 4 ] The most common side effects seen in cats include vomiting , diarrhea , injection site pain, scabbing on the head and neck, dermatitis , and pruritus (itchy skin).
Individual dogs of any breed can have a profound reaction characterized by hypotension, especially if there is an underlying heart problem. In giant-breed dogs and sighthounds, the sedative effects of acepromazine may last for 12–24 hours, which is much longer than the usual 3–4 hours. [16] [20]
The post Apoquel for Cats: Uses, Dosage, & Side Effects appeared first on CatTime. Apoquel is a medication prescribed for pets — particularly dogs — to alleviate symptoms associated with ...
The post Penicillin for Cats: Uses, Dosage, & Side Effects appeared first on CatTime. It falls under the beta-lactam class of antibiotics and is primarily used to treat bacterial infections.
Deracoxib is a coxib class nonsteroidal anti-inflammatory drug (NSAID). [3] Like other NSAIDs, its effects are caused by inhibition of cyclooxygenase (COX) enzymes. [7] At the doses used to treat dogs, deracoxib causes greater inhibition of COX-2 than of COX-1, [3] but at doses twice those recommended for use in dogs, deracoxib significantly inhibits COX-1 as well.
Most dogs, however, will need radiation, chemotherapy, and other medications. Even with those therapies, the survival time is short, so ivermectin could help if it proves to be useful.
The most common side effects of bupivacaine/meloxicam are dizziness, constipation, vomiting, and headache. [ 1 ] [ 2 ] It was authorized for medical use in the European Union in September 2020, [ 2 ] and approved in the United States in May 2021.